CD274 and neoplasm: Individual immunograms including tumor neoantigen prediction, factors affecting the tumor-host interaction such as PD-L1 expression, gut microbiota composition, patient germline genetics, immune microenvironment composition as well as absence/presence of soluble inhibitory molecules may help to distinguish responders from non-responders to ICI.